CLOs on the Move

Conversion Labs

www.conversionlabs.com

 
Conversion Labs, Inc. is an emerging leader in technology driven healthcare. We`re applying our direct-to-consumer marketing expertise to make access to high quality prescription medications and OTC products convenient, cost-effective, and simple. Our brands are intensely focused on our consumers, constantly striving to deliver a better end-to-end healthcare experience through technology. Our mission is to create and sell amazing products that improve the health and happiness of our customers.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Eric Yecies
Chief Compliance Officer and General Counsel Profile

Similar Companies

MGC Diagnostics Corporation

MGC Diagnostics Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mission Athletecare

MISSION is the first and only line of athlete-engineered products designed to enhance performance in training and competition. Co-founded in 2009 by a premier group of world-class athletes including Serena Williams, Dwyane Wade, Sergio Garcia, David Wright, Reggie Bush and Mia Hamm, MISSION boasts more than 25 high-performance product innovations and is sold in nearly 20,000 stores across the U.S. MISSION works with its world-renowned athletes, doctors and scientists to engineer products that help athletes prepare, perform and rehab from training or competition.

Oxtel

Oxtel is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Meadowbrook Healthcare

Meadowbrook Healthcare is a Plattsburgh, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nymox

NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.